Navigation Links
BUSM researchers identify key regulator of inflammatory response
Date:4/12/2012

(Boston) Researchers at Boston University School of Medicine (BUSM) have identified a gene that plays a key role in regulating inflammatory response and homeostasis. These findings could help lead to the development of innovative methods to reduce the inflammation associated with cancer, type 2 diabetes and other diseases.

The study, which was led by Valentina Perissi, PhD, assistant professor of biochemistry at BUSM, was done in collaboration with the Howard Hughes Medical Institute (HHMI) at the University of California, San Diego. The results are published online and will be in the April 13 print issue of Molecular Cell.

Cells respond to inflammation by producing cytokines, which are cellular signaling protein molecules that allow for intercellular communication. Cytokines, such as TNF-alpha for example, bind to specific receptors on cellular membranes, activating an intracellular signaling process.

In this study, researchers looked at a gene called GPS2, which was previously known to regulate gene expression in the nucleus. This study found that GPS2 plays a critical role at the cellular membrane level to negatively regulate the signaling cascade activated by TNF-alpha. As a result, they observed that increasing GPS2 levels was sufficient to impair the response to TNF-alpha, resulting in a decreased inflammatory response.

Given this information, the researchers then examined whether having more GPS2 in fat tissue would help reduce the development of insulin resistance in conjunction with obesity. The results were promising as insulin signaling in the fat tissue was greatly improved. However, overexpression of GPS2 in the nucleus also had a negative effect on liver function.

"Our study demonstrates that GPS2 plays an important regulatory function in mitigating inflammation," said Perissi, who served as the study's senior author. "These findings have uncovered a potential new target for therapeutic trea
'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers call for a new direction in oil spill research
2. Researchers identify Achilles heel of dengue virus, target for future vaccines
3. Researchers find critical regulator to tightly control deadly pulmonary fibrosis
4. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
5. Researchers identify genes that may help in ovarian cancer diagnosis and prognosis
6. Researchers use game to change how scientists study disease outbreaks
7. Notre Dame researchers using novel method to combat malaria drug resistance
8. BU researchers derive purified lung and thyroid progenitors from embryonic stem cells
9. Researchers report potential for a moderate New England red tide in 2012
10. Tales from the crypt lead researchers to cancer discovery
11. Researchers identify new regulator in allergic diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... who were treated with anti-tumor necrosis factor alpha, ... exacerbations than individuals taking a placebo. , This ... 2006 of the American Journal of Respiratory and ... Society. , Trevor T. Hansel, M.D., Ph.D., of ...
... the degenerative inflammatory bone disease, may be a sign of ... the Annals of the Rheumatic Diseases. , The authors base ... between 30 and 79. Most of them were female twins. ... to check for signs of osteoarthritis and a blood sample ...
... of Virology and Immunology (GIVI) have identified a previously unknown ... a finding that may lead to new approaches for controlling ... 2, 2006, in Proceedings of the National Academy of Sciences, ... of GIVI Director Warner C. Greene, MD, PhD, explains why ...
Cached Biology News:Monoclonal antibody reduces exacerbations in asthmatics 2Osteoarthritis may be sign of faster 'biological ageing' 2Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G 2
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. ... ended March 31, 2015. Aviv ... we continued pre-clinical work to generate functional specific antibodies, ... early stage, we are encouraged by the development progress. ... as new antibodies which modulate immune checkpoints gain clinical ...
(Date:5/27/2015)... Calif. , May 27, 2015  CytomX, ... treatment of cancer, today announced the appointments of ... and Cynthia Ladd as senior vice ... Goeltz was chief financial officer of Onyx Pharmaceuticals, ... an independent consultant and legal counsel to several ...
(Date:5/27/2015)... THOUSAND OAKS, Calif. , May 27, 2015 /PRNewswire/ ... company, has been awarded a U.S. patent for a ... gene in areas such as research, product development and ... useful in regulating key biosynthetic processes that are the ... to offer other seed companies a commercial license to ...
(Date:5/27/2015)... Madison, NJ (PRWEB) May 27, 2015 ... for evaluating the impact of regulation on medical innovation, ... Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( ... inaugural MI3 Alert pertains to new FDA ... Senate proposal for accelerating the approval of certain medical ...
Breaking Biology Technology:Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2
... confer risk of, common diseases is empowering individuals to explore ... Webcast ... deCODE genetics,(Nasdaq: DCGN ) today announced the launch of deCODEme(TM), ... own,genome. Through your subscription to deCODEme(TM), you can learn what your ...
... Annual Analyst Day for Institutional Investors and Financial Analysts on ... November ... November 27 - - 19th Annual Piper Jaffray Health Care Conference on ... ) announced today that the Company will webcast its annual,meeting with institutional investors ...
... Nov. 15 Martek Biosciences,Corporation (Nasdaq: MATK ... European Patent Office (EPO) has ruled in favor ... docosahexaenoic acid (DHA) patents. The,modified claims of the ... broader than the claims that were previously upheld ...
Cached Biology Technology:deCODE Launches deCODEme(TM) 2deCODE Launches deCODEme(TM) 3deCODE Launches deCODEme(TM) 4Gen-Probe to Webcast Three Upcoming Presentations 2European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed 2European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed 3
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
C/EBPdelta Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
Biology Products: